All stock lists
Unlock the score
CVRx, Inc. (NASDAQ:CVRX)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
1.45+0.03 (+2.11%)
Market cap
$38.6M
Insider Score
Health Score
Analyst consensus
Listed since
Jun 30, 2021
Website
Insider Score
/ 100
CVRX Insider Score
CVRx, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
CVRX Stock Insider Trading Activity
CVRX stock’s insider trading shows 1 purchase for an estimated $76.43K and 1 sale on the open market for an estimated $3.34K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days1 qualifying buy1 insider$76.43K bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Binkowski Brent COO | Buy | 26,223 | $2.91 | $76.43K | 86.6% | 56,514 | Aug 13, 2026 | A+First BuyExec Buy | Form 4 |
| Binkowski Brent COO | Sell | 1,309 | $2.55 | $3.34K | 4.1% | 30,291 | Aug 12, 2026 | — | Form 4 |
| Nielsen Kirk G. Director | Award | 8,720 | — | — | New | 8,720 | Jun 1, 2026 | — | Form 4 |
| Jain Mudit K. Director | Award | 8,720 | — | — | 154% | 14,370 | Jun 1, 2026 | — | Form 4 |
| SLATTERY JOSEPH P Director | Award | 8,720 | — | — | 28.5% | 39,365 | Jun 1, 2026 | — | Form 4 |
| Hill, Mitch C. Director | Award | 8,720 | — | — | New | 8,720 | Jun 1, 2026 | — | Form 4 |
| Ballinger Kevin J. Director | Award | 8,720 | — | — | New | 8,720 | Jun 1, 2026 | — | Form 4 |
| SHADAN MARTHA Director | Award | 8,720 | — | — | New | 8,720 | Jun 1, 2026 | — | Form 4 |
| DALE MICHAEL D Director | Award | 29,005 | — | — | New | 29,005 | Jun 1, 2026 | — | Form 4 |
| Morrison Gregory Other | Award | 34,000 | — | — | New | 34,000 | Mar 2, 2026 | — | Form 4 |
| Hykes Kevin CEO | Sell | 7,763 | $7.90 | $61.33K | 2.7% | 284,237 | Mar 2, 2026 | — | Form 4 |
| John Robert Allen Other | Sell | 3,964 | $7.90 | $31.32K | 4.4% | 86,036 | Mar 2, 2026 | — | Form 4 |
| OASHEIM JARED CFO | Sell | 1,744 | $7.90 | $13.78K | 1.8% | 96,703 | Mar 2, 2026 | — | Form 4 |
| VERRASTRO PAUL Other | Sell | 1,284 | $7.90 | $10.14K | 2.1% | 60,551 | Mar 2, 2026 | — | Form 4 |
| Adamson Philip B. Other | Sell | 1,262 | $7.90 | $9.97K | 2.0% | 61,578 | Mar 2, 2026 | — | Form 4 |
| Hykes Kevin CEO | Award | 159,000 | — | — | 120% | 292,000 | Feb 27, 2026 | — | Form 4 |
| Adamson Philip B. Other | Award | 41,000 | — | — | 188% | 62,840 | Feb 27, 2026 | — | Form 4 |
| VERRASTRO PAUL Other | Award | 45,000 | — | — | 267% | 61,835 | Feb 27, 2026 | — | Form 4 |
| OASHEIM JARED CFO | Award | 61,000 | — | — | 163% | 98,447 | Feb 27, 2026 | — | Form 4 |
| Binkowski Brent COO | Award | 15,000 | — | — | 90.4% | 31,600 | Feb 27, 2026 | — | Form 4 |
| John Robert Allen Other | Award | 35,000 | — | — | 63.6% | 90,000 | Feb 27, 2026 | — | Form 4 |
| Jain Mudit K. Director | Buy | 46,800 | $6.36 | $297.65K | 5.0% | 980,183 | Feb 20, 2026 | BBuying Weakness | Form 4 |
| Jain Mudit K. Director | Buy | 600 | $4.64 | $2.78K | 11.9% | 5,650 | Feb 18, 2026 | CFirst BuyBuying Weakness | Form 4 |
| JOHNSON & JOHNSON Other | Sell | 6,337 | $10.03 | $63.56K | 0.2% | 4,040,861 | Nov 26, 2025 | — | Form 4 |
| JOHNSON & JOHNSON Other | Sell | 2,200 | $10.06 | $22.13K | 0.1% | 4,047,198 | Nov 24, 2025 | — | Form 4 |
| JOHNSON & JOHNSON Other | Sell | 500 | $10.00 | $5.00K | 0.0% | 4,049,398 | Nov 21, 2025 | — | Form 4 |
| JOHNSON & JOHNSON Other | Sell | 1,000 | $10.00 | $10.00K | 0.0% | 4,049,898 | Nov 12, 2025 | — | Form 4 |
| Johnson & Johnson Innovation - JJDC, Inc. Other | Sell | 200 | $10.00 | $2.00K | 0.0% | 4,050,898 | Nov 7, 2025 | — | Form 4 |
| Johnson & Johnson Innovation - JJDC, Inc. Other | Sell | 52,332 | $10.21 | $534.31K | 1.3% | 4,051,098 | Nov 6, 2025 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Sell (S) — Open-market or private sale
- Award (A) — Grant or award from the company, not a purchase
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.